The activation of downstream effectors of Ras signaling such as MEK1/2 occurs in 91% of MPNST patient tissue samples, as compared to 21% of benign neurofibromas [10], and contributes to the proliferation and survival of MPNST cell lines [11]. The gene discussed is MAP2K1; the disease is plexiform neurofibroma.